To share emerging therapies and surgical approaches in retina care during the 50th Atlantic Coast Retina Club and Macula conference, marking a significant milestone in the field.
Approach:
Key Findings:
Significant drop in systemic cell-free DNA after enucleation in a retinoblastoma case led to intra-arterial chemotherapy decision.
Intra-arterial chemotherapy was effective for metastatic cutaneous melanoma in the subretinal space.
A case of choroidal thickening in a diabetic patient resolved after discontinuing dulaglutide, highlighting the need for understanding GLP-1 receptor agonists' ocular side effects.
Inflammatory mimickers of retinal diseases were discussed, emphasizing the need for comprehensive evaluations.
Emerging therapies like intravitreal tyrosine kinase inhibitors show promise in treating diabetic retinopathy.
Interpretation:
The conference highlighted the importance of case-based learning and the evolving landscape of retinal therapies, emphasizing the need for ongoing education and adaptation in clinical practice.
Limitations:
The conference was limited to presentations and discussions, lacking extensive longitudinal data on the emerging therapies, which may affect the reliability of the findings.
Real-world applicability of discussed therapies may vary and requires further validation through clinical trials.
Conclusion:
The Atlantic Coast Retina Club and Macula 2026 conference served as a significant platform for sharing knowledge and advancements in retinal care, reinforcing the importance of continuous learning in the field through case studies and expert insights.
